Platelet Function Analysis in Head Trauma: ASA/Plavix
NCT01534117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97
Last updated 2012-02-16
Summary
The investigators are assessing the platelet function analysis of those who sustained significant head trauma while on aspirin or plavix and to assess if any qualitative difference is obtained if platelets are administered.
Conditions
- Head Injury Trauma Blunt
Interventions
- BIOLOGICAL
-
Platelets
1 unit of platelets
- DRUG
-
DDAVP
Desmopressin 0.3mcg/kg IV x 1
Sponsors & Collaborators
-
Santa Barbara Cottage Hospital
collaborator OTHER -
Accumetrics, Inc.
collaborator INDUSTRY -
Chang, Steve S., M.D.
lead INDIV
Principal Investigators
-
Steve S Chang, MD · Santa Barbara Cottage Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-11-30
- Completion
- 2011-11-30
Countries
- United States
Study Locations
More Related Trials
-
The Antiplatelet and Immune Response Trial
NCT01846559 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
NCT00827346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reversibility of Dual Antiplatelet Therapy by Platelets
NCT01248351 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects
NCT01307657 ·Status: COMPLETED ·Phase: NA
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
NCT00386191 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Testing Help and Intraoperative Bleeding Risk for Patients Who Are on Plavix Prior to Surgery
NCT00653900 ·Status: WITHDRAWN
-
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01339026 ·Status: TERMINATED ·Phase: PHASE4
-
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
NCT03431142 ·Status: COMPLETED ·Phase: PHASE4
-
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients
NCT03385538 ·Status: COMPLETED ·Phase: PHASE4
-
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
NCT04237935 ·Status: COMPLETED
-
Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)
NCT02094755 ·Status: COMPLETED
-
Effects of Clopidogrel on Blood Pressure
NCT01112137 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657 ·Status: COMPLETED ·Phase: NA
-
The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry
NCT04822363 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigation of the Athero-Protective Effects of Clopidogrel
NCT01283282 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
NCT00728156 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Reactivity And Clinical ThrombotIC Events Study
NCT03525145 ·Status: UNKNOWN
-
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
NCT05047172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.
NCT03103685 ·Status: UNKNOWN ·Phase: PHASE4
-
Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma
NCT01264640 ·Status: UNKNOWN ·Phase: NA
-
Pharmacogenomics of Antiplatelet Response - I
NCT01815008 ·Status: COMPLETED ·Phase: PHASE4
-
Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects
NCT01129271 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Inhibition in the Acute Phase of STEMI
NCT01144819 ·Status: COMPLETED
-
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
NCT06223607 ·Status: RECRUITING